David C Hohn Net Worth & Insider Trades
David C Hohn - Director, Cleveland Biolabs Inc
What is David C Hohn's Net Worth?
The current estimated net worth of Cleveland Biolabs Inc's Director, David C Hohn, is estimated to be about $5.13K . David C Hohn owns about 9,584 units of Cleveland Biolabs Inc common stock. In the last 2 years at Cleveland Biolabs Inc, David C Hohn has sold an estimated value of $0 worth.
What is David C Hohn's Past Insider Trading?
David C Hohn's largest purchase order was 1,000 units , worth over $1.71K on April 6, 2012. In total, David C Hohn has made about 7 transactions over 2 years of their time at Cleveland Biolabs Inc. David C Hohn usually trades in June, with the busiest year in 2012. The most recent transaction was a purchase order of 1,000 units , worth over $1.61K on July 5, 2012.
David C Hohn
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is David C Hohn's' Mailing Address?
- Mailing address is C/o Cleveland Biolabs, Inc. 73 High Street Buffalo NY 14203 NY
Cleveland Biolabs Inc Executive Compensation
Name |
Year
|
Salary
|
Other Compensation
|
Total
|
|---|---|---|---|---|
| Langdon L. Miller | 2019 | $73,725 | - | $77,625 |
| Langdon L. Miller | 2018 | $119,550 | - | $119,550 |
| Andrei Gudkov | 2019 | $66,138 | - | $66,138 |
| Andrei Gudkov | 2018 | $110,941 | - | $110,941 |
| Christopher Zosh | 2019 | $92,463 | $11,031 | $103,494 |
| Christopher Zosh | 2018 | $73,031 | $9,161 | $82,192 |
| Yakov Kogan | 2019 | $264,323 | $50,607 | $314,930 |
| Yakov Kogan | 2018 | $276,000 | $10,800 | $286,800 |
| No matching records found | ||||
Source: https://www.sec.gov/Archives/edgar/data/1318641/000143774920023024/cbli20201029_def14a.htm
What are Cleveland Biolabs Inc's Past Insider Trades?
Cleveland Biolabs Inc's most recent insider trade came on February 27, 2015 by Randy S Saluck who bought 1,891 units worth $6.47K . In the last 8 years, insiders at Cleveland Biolabs Inc have sold an estimated value of $1.16M and bought an estimated value of $275.69K worth of shares. Insider trading is most common in June, with the busiest year in 2010. The most active traders at the company are Yakov Kogan, Chief Executive Officer, Andrei Gudkov, Chief Scientific Officer, and Michael Fonstein, President .
Cytocom, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||